AYELET MOTTAHEDEH: Open Payments
NPI 1154697753 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 86 payments from 15 companies in 2025. Trend: 2023 $558 · 2024 $1,085 · 2025 $1,600
Food & beverage: $1,600
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $421 |
| Ardelyx, Inc. | 18 | $309 |
| Madrigal Pharmaceuticals | 10 | $218 |
| Janssen Biotech, Inc. | 13 | $212 |
| PFIZER INC. | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
| GENZYME CORPORATION | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| QOL Medical, LLC | 1 | $44 |
| Novo Nordisk Inc | 2 | $30 |
Products named: IBSRELA, REZDIFFRA, TREMFYA, CREON, RINVOQ, DUPIXENT, XELJANZ, SKYRIZI.
Industry payments across NY — which companies pay providers there.
